- Advertisement -

Biotechnology project to reduce mercury pollution in marine sediments – Mirage News

Biotechnology project to reduce mercury pollution in marine sediments The UAB participates in the MER-CLUB initiative to develop a technology based on the use of...

New technology can rapidly disrupt existing biofilms that account for chronic diseases

Chronic and recurrent bacterial diseases are treatment-resistant due to the ability of the pathogens to establish biofilms, which act as fortresses built of extracellular...

Researchers investigate the effect of palm oil extract on mice liver cells

Reviewed by Emily Henderson, B.Sc.Nov 4 2020 Palm oil contains abundant quantities of vitamin E compounds, which include tocopherols and tocotrienols. These compounds have anti-oxidant effects,...

Sunnier but riskier

Conservation efforts to open up rattlesnake habitat bring in much-needed sunlight but could attract more threatening predators Credit: Christopher Camacho

Fujifilm Diosynth Plans $2B Cell Culture Facility in Holly Springs, NC

A rendering of Fujifilm Diosynth Biotechnologies’ planned $2 billion cell culture manufacturing facility. The company is eligible for up to $21.7 million in state...

Aging: Separating the Science from the Snake Oil

Broadcast Date: May 17, 2023Time: 9:00 am PT, 12:00 pm ET, 18:00 CET REGISTER NOW In the field of aging research, the line...

Nanomedicine research aims to transform treatment of aortic aneurysms

Aortic aneurysms are bulges in the aorta, the largest blood vessel that carries oxygen-rich blood from the heart to the rest of the body....

SolasCure publishes phase IIa clinical trial report in leading wound care...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, has today announced the publication of its CLEANVLU Phase...

Nanomedicine research aims to transform treatment of aortic aneurysms

Aortic aneurysms are bulges in the aorta, the largest blood vessel that carries oxygen-rich blood from the heart to the rest of the body....

SolasCure publishes phase IIa clinical trial report in leading wound care journal

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, has today announced the publication of its CLEANVLU Phase...

Boston Strong: Novo Nordisk Expands U.S. Research and Early Development

Jacob Petersen, DMSc, Novo Nordisk senior vice president, head of global nucleic acid therapies LEXINGTON, MA—For Jacob Petersen, DMSc, Novo Nordisk’s quest to treat...

more new items

Nanomedicine research aims to transform treatment of aortic aneurysms

Aortic aneurysms are bulges in the aorta, the largest blood vessel that carries oxygen-rich blood from the heart to the rest of the body....

SolasCure publishes phase IIa clinical trial report in leading wound care...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, has today announced the publication of its CLEANVLU Phase...

Boston Strong: Novo Nordisk Expands U.S. Research and Early Development

Jacob Petersen, DMSc, Novo Nordisk senior vice president, head of global nucleic acid therapies LEXINGTON, MA—For Jacob Petersen, DMSc, Novo Nordisk’s quest to treat...